THE FUTURE OF NON-INVASIVE RESPIRATORY MONITORING

01

No tubes. No wires.

Non-invasively monitors patient’s breathing, gives reliable alerts for deteriorating volumes, apnea and obstructive breathing

02

Cost-effective

Monitors breathing at a fraction of the cost of existing monitoring technologies by utilizing off-the-shelf hardware.

03

Intuitive & Simple

Straight-forward to use and interpret by all medical staff. Output consists of standard respiratory parameters.

MEET BREATHEVISION

OUR STORY

BreatheVision was founded in 2013 on the need to develop a simple method for early detection of breathing deterioration in patients under conscious sedation... The founders built on their expertise in machine vision and missile navigation algorithms to invent a way to quantify breathing through analyzing chest micro-movements based on low-cost off the shelf hardware.

OUR VISION

To improve patient safety by monitoring essential breathing parameters through machine learning technology and providing immediate warning.

OUR PRODUCT

Our first product, the SafeSed monitoring system, was developed for medical staff to continuously monitor respiration for post anesthesia sedated patients.

 
 
 
Ziv Geva
CTO

??????

Scientific Advisor

Professor of Information Systems at the Computer Science Department at Technion, University of Haifa (Israel)

PROSPECTIVE TARGET MARKETS

COVID-19 respiratory monitoring
Post
anesthesia
monitoring
Procedural
sedation
Neonatal
hospital
monitoring
Remote and
home 
monitoring

MEDICAL NEED

Adverse events associated with sedation
“Drug-induced respiratory depression is the primary cause of morbidity associated with sedation and analgesia”
American Society of Gastroenterology Nurses and Associates 2016
Continuous respiratory monitoring

"…hospitals are expected to address monitoring for …respiratory

depression related to opioids for post-operative patients…. monitoring of ventilation may warrant … to assess breathing"

Current monitoring methods

“Staff should … not to rely on pulse oximetry alone because pulse oximetry can suggest adequate oxygen saturation in patients … experiencing respiratory depression, especially when supplemental oxygen is being used.”

The Joint Commission Sentinel Event Alert, 2012

“Capnography devices often indicate problems where none exist… At worst, frequent alarm errors may lead to alarm fatigue and a tendency to ignore valid alarms.”

American Society for Gastrointestinal Endoscopy, 2012
Future monitoring methods

“Quantitative monitoring of the volume of expired gas is strongly encouraged.”

American Society of Anesthesiologists, 2015
Apnea
Obstructive
Shallow

SafeSed - No Tubes, No Wires

Simply Brilliant!​

CLINICAL VALIDATION

BreatheVision performed clinical validation of the SafeSed monitoring system at Meir Medical Center (Kfar Saba, Israel) and Tel-Aviv Medical Center.
The SafeSed system was compared to conventional means of respiratory monitoring:
  • Colonoscopy - SafeSed vs. Capnography
  • Operation Room - SafeSed vs. Anesthesia Machine
  • Healthy Volunteers - SafeSed vs. Spirometry
  • PACU post anesthesia - SafeSed vs. Pulse Oximetry and Clinical Logs
 

SafeSed signal vs. Capnograph signal

 

SafeSed signal vs. Spirometer signal

 
 

OUR NEWS

1st clinical trial for SafeSed in the Gastro clinic began recruiting at Meir Medical Centre, Israel.

DEC.

2016
1st US Patent granted for the SafeSed system. 

OCT.

2017
Successful FDA Pre-Submission meeting for the SafeSed device.

APR.

2018

AUG.

First round of crowd-funding completed.
Second round during Q1 2020.
Total of 4.5M NIS raised.
2019

AUG.

2018
Clinical Validation Trial for Volume determination by SafeSed vs. Anesthesia machine at Meir Medical Centre, Israel has completed successfully

FEB.

Healthy Volunteers Clinical Trial for performance and accuracy evaluation of SafeSed at Meir Medical Centre, Israel has been completed successfully.
2020

APR.

4th Grant from the Israel Innovation Authority for COVID-19 Pilot.
2020

DEC.

2nd US Patent granted for the SafeSed system. 
2019

OCT.

Pilot in PACU for respiratory deterioration monitoring and prediction by SafeSed began recruiting at Tel-Aviv Medical Centre, Israel. 
2020

JUN.

Completed development of a Central Monitoring System for remote monitoring of multiple COVID-19 patients simultainesly.
2020
2020
 
 
 
 
 
 

Respiratory rate

(number of breaths in 

one minute)

Minute ventilation

(total amount of air inhaled or exhaled in one minute)

 Tidal volume

(amount of air moved

with each breath)

Our algorithm analyzes the measured data, alerts on breathing deterioration, and displays continuously the following breathing parameters:
SafeSed recognizes deterioration
in patient’s breathing that requires
immediate medical attention.

OUR TEAM

Menashe Terem
CEO
Ditza Aurebach
Founder
Ziv Geva
CTO
Ofer Leizerovich
 
Omri Tzur
Clinical Project Manager
Omri Cohen
Project Manager
Ofer Orgal
Avi Kriheli
Menashe Terem, MA
CEO & Co-Founder

Former executive at El-Al Airlines who also led several medical device companies into OTC and professional markets worldwide.

Ditza Auerbach, PhD
Founder

Physicist experienced in leading imaging and machine learning R&D at Aspect Imaging and Applied Materials. 

Ziv Geva
CTO
Prof. Ilan Shimshoni
Scientific Advisor

Professor of Information Systems at the Computer Science Department at Technion, University of Haifa (Israel)

PROSPECTIVE TARGET MARKETS

COVID-19 respiratory monitoring
Post-anesthesia
monitoring
Procedural
sedation
Remote and home monitoring
Neonatal
hospital
monitoring

MEDICAL NEED

Adverse events associated with sedation
“Drug-induced respiratory depression is the primary cause of morbidity associated with sedation and analgesia”
American Society of Gastroenterology Nurses and Associates 2016
Continuous respiratory monitoring

"…hospitals are expected to address monitoring for …respiratory

depression related to opioids for post-operative patients…. monitoring of ventilation may warrant … to assess breathing"

Centers for Medicare & Medicaid Services (CMS), 2014 
Current monitoring methods

“Staff should … not to rely on pulse oximetry alone because pulse oximetry can suggest adequate oxygen saturation in patients … experiencing respiratory depression, especially when supplemental oxygen is being used.”

 
The Joint Commission Sentinel Event Alert, 2012

“Capnography devices often indicate problems where none exist… At worst, frequent alarm errors may lead to alarm fatigue and a tendency to ignore valid alarms.”

American Society for Gastrointestinal Endoscopy, 2012

“No studies have been published on the effectiveness of capnography on clinically important outcomes (rescue team activation, ICU transfers, or mortality). Etco2 may not accurately reflect the Paco2 in nonintubated patients in the setting of low-tidal volume breathing or mouth breathing... Capnography may require extra training of staff members before implementation.”

Anesthesia & Analgesia; Vol. 125 Issue 6, 2017
Future monitoring methods

“Quantitative monitoring of the volume of expired gas is strongly encouraged.”

American Society of Anesthesiologists, 2015

OUR

TECHNOLOGY

SafeSed recognizes deterioration in patient's breathing that requires immediate medical attention.
SafeSed has been developed for medical staff, to continuously monitor respiration.
Apnea
Obstructive
Shallow

SafeSed - No Tubes, No Wires

Simply Brilliant!​

CLINICAL VALIDATION

BreatheVision performed clinical validation of the SafeSed monitoring system at Meir Medical Center (Kfar Saba, Israel) and Tel-Aviv Medical Center.
The SafeSed system was compared to conventional means of respiratory monitoring:
  • Colonoscopy - SafeSed vs. Capnography
  • Operation Room - SafeSed vs. Anesthesia Machine
  • Healthy Volunteers - SafeSed vs. Spirometry
  • PACU post anesthesia - SafeSed vs. Pulse Oximetry and Clinical Logs
 

SafeSed signal vs. Capnograph signal

 

OUR NEWS

1st clinical trial for SafeSed in the Gastro clinic began recruiting at Meir Medical Centre, Israel.

DEC.

2016

DEC.

2nd US Patent granted for the SafeSed system. 
2019
1st US Patent granted for the SafeSed system. 

OCT.

2017
2020
Completed development of a Central Monitoring System for remote monitoring of multiple COVID-19 patients simultainesly.

JUN.

Successful FDA Pre-Submission meeting for the SafeSed device.

APR.

2018

FEB.

2020
Healthy Volunteers Clinical Trial for performance and accuracy evaluation of SafeSed at Meir Medical Centre, Israel has been completed successfully.
Clinical Validation Trial for Volume determination by SafeSed vs. Anesthesia machine at Meir Medical Centre, Israel has completed successfully.

AUG.

2018

APR.

4th Grant from the Israel Innovation Authority for COVID-19 Pilot.
2020
First round of crowd-funding completed. Second round during Q1 2020. Total of 4.5M NIS raised.

AUG.

2019

OCT.

Pilot in PACU for respiratory deterioration monitoring and prediction by SafeSed began recruiting at Tel-Aviv Medical Centre, Israel. 
2020
 

STAY IN TOUCH

Tel: +972-(0) 8-672-0512
BreatheVision Ltd.
6 Harash st.
Nes Ziona 7403113
Israel
 
LINKS
ABOUT

info@breathevision.com

Tel: +972-(0) 8-672-0512

BreatheVision Ltd.

6 Harash st.

Nes Ziona 7403113, Israel

SOCIAL
  • White LinkedIn Icon
  • White Facebook Icon
  • White Twitter Icon
  • White Google+ Icon